BridgeMD
New treatment option for Alzheimer's Disease
Official title Social & Affective Cognition in Alzheimer's Disease & Associated Disorders
ClinicalTrials.gov ID: NCT06338397
What this study is testing
- What it's testing
- Recent studies have shown that individual neuropsychological scores of patients with Alzheimer's disease and Associated Disorders (ADAD) are only poorly correlated to their behavioral difficulties, such as disinhibition, apathy, social decision-making or vulnerability. Recently, social \& affective cognitive disorders have been highlighted as potential cause of social behavioral abnormalities.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 40 to 85. Healthy volunteers may be eligible.
You may be able to join if
- Men and women;
- 40 to 85 years of age (included);
- Registered with the French Social Security;
- Have a study partner. The study partner is required to complete several scales. If the people or their study partners are not able to drive, their...
- Fluent in French, able to read and write;
You likely can't join if
- Participants who have contraindications to perform an MRI scan;
- Participants with significant sensory deficits that are not corrected by suitable devices.
- Participants with dementia caused by a non-neurodegenerative disease, including patients with severe cerebrovascular risk factor load, in the...
- Participants with other neurodegenerative disease such as Lewy body dementia and Parkinson's disease;
- Participants with other serious neurological disorder such as brain tumor, stroke, epilepsy, hydrocephalus and any condition which contraindicates...
- Participants with excessive alcohol intake or drug abuse, in the judgment of the investigator;
See the full eligibility criteria
- Men and women;
- 40 to 85 years of age (included);
- Registered with the French Social Security;
- Have a study partner. The study partner is required to complete several scales. If the people or their study partners are not able to drive, their transport fees will be reimbursed by the promotor.
- Fluent in French, able to read and write;
- Participants who have contraindications to perform an MRI scan;
- Participants with significant sensory deficits that are not corrected by suitable devices.
- Participants with dementia caused by a non-neurodegenerative disease, including patients with severe cerebrovascular risk factor load, in the judgment of the investigator;
- Participants with other neurodegenerative disease such as Lewy body dementia and Parkinson's disease;
- Participants with other serious neurological disorder such as brain tumor, stroke, epilepsy, hydrocephalus and any condition which contraindicates, in the investigator's judgment, entry to the study;
- Participants with excessive alcohol intake or drug abuse, in the judgment of the investigator;
- Participants who, in the opinion of the investigator, have a risk of non-compliance to the study procedures;
The study team makes the final eligibility decision.
Where it's taking place
- Lille, France
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 40 years to 85 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Lille, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.